[5-Methyl-1-(oxan-2-yl)-1H-indazol-4-yl]boronic acid, 95.0%, 500mg

Cono de sedimentación según para Imhoff con llave de paso, 1 pieza

2-(tert-Butyl)pyridin-3-amine, 95%, 1g

5-(2-FLUOROPHENYL)-1H-PYRROLE-3-CARBOXYLIC ACID METHYL ESTER, 95.0%, 250mg

(2-((2,4-Dichlorobenzyl)oxy)phenyl)boronic acid, 95.0%, 1g

Plan de larga distancia de trabajo fase 20x/0,40 Objetivo IOS, distancia de trabajo 6,92 mm

5-(5-methylfuran-2-yl)-1H-pyrazole, 95.0%, 5g

O1-Benzyl O3-methyl 3-fluoropyrrolidine-1,3-dicarboxylate, 98%, 5g

3-[4-(propan-2-yl)phenyl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

6-Methyloctahydro-1H-pyrrolo[3,4-b]pyridine, 95.0%, 250mg

4-ethyl-3-(2-{pyrazolo[1,5-a]pyrimidin-6-yl}ethynyl)benzoic acid, 97.0%, 500mg

4-Nitrofenil-N-acetil-β-D-glucosaminida, 500 mg

2,4-Dimethoxybenzoylacetonitrile, 95.0%, 500mg